About Dexcom
Dexcom is a global leader in continuous glucose monitoring, providing real-time glucose data and AI-powered insights for diabetes management.
Mission & Story
Mission
Dexcom empowers people to take control of health through innovative glucose biosensing technology.
Founding Story
Since 1999, Dexcom has been developing innovative technology that has transformed how people manage diabetes and track their glucose. The company has set the standard in glucose biosensing for 25 years and counting.
Clinical Focus
Medical conditions and clinical areas addressed by Dexcom.
Who It Serves
Milestones & Awards
Recent Milestones
Launched Stelo as first over-the-counter CGM (2024-2025). Introduced Dexcom G7 direct-to-watch feature. Formed Customer Advisory Council in January 2026. Celebrating 25+ years in glucose biosensing technology.
Awards & Recognition
Recognized as world's most powerful CGM system and leader in glucose sensing technology with best-in-class accuracy claims.
Key Partnerships
Social & Media
Follow on
Company Details
- Founded
- 1999
- Headquarters
- San Diego, CA, USA
- Employees
- 10001
- Stage
- public
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingSecurity & Compliance
Official Sources
Similar Companies in this Market
View all 46 →Abbott Diabetes Care
Abbott Diabetes Care develops FreeStyle Libre, a world-leading continuous glucose monitoring (CGM) portfolio for diabetes management with advanced analytics and innovation.
Amalgam Rx
Amalgam Rx develops AI-powered digital therapeutics and Software as a Medical Device (SaMD) solutions for chronic disease management. The company partners with life sciences companies, health plans, and providers to deliver regulated digital health applications and EHR-integrated clinical decision support tools.
Arkray
ARKRAY USA manufactures and distributes blood glucose monitoring systems, clinical diagnostic equipment, and oral wellness products. The company serves consumers with diabetes, healthcare professionals, and clinical laboratories with accurate, affordable diagnostic solutions.
BeatO
BeatO is a digital health platform specializing in diabetes management and weight loss solutions. The company offers smart glucose monitoring devices, GLP-1 weight loss programs, and a comprehensive diabetes care program combining connected devices, doctor consultations, and health coaching for over 2 million patients across India.
Brook Health
AI-powered remote patient monitoring and chronic disease management platform for conditions like diabetes, hypertension, and heart disease.
Cadence
Cadence delivers AI-powered remote patient care programs for chronic disease management. The company partners with health systems, payers, and medical groups to provide 24/7 monitoring, medication management, and clinical support for patients with hypertension, heart failure, diabetes, and other chronic conditions.
Cala Health
Cala Health develops the Cala kIQ System, an FDA-cleared wearable device that delivers non-invasive neuromodulation therapy for action hand tremor. The device uses transcutaneous afferent patterned stimulation (TAPS) to provide on-demand tremor relief for people with essential tremor and Parkinson's disease.
Calibrate
Calibrate is a metabolic health company that combines clinician-prescribed GLP-1 medications with 1:1 video coaching and science-backed curriculum to help members achieve sustainable weight loss. Members lose an average of 19% of their body weight achieved over three years.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.
